A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.

Details

Language :

English

Volume :

61

Issue :

9

Database :

Complementary Index

Journal :

Arthritis & Rheumatism: Arthritis Care & Research

Publication Type :

Academic Journal

Accession number :

62406957

Full Text :

https://doi.org/10.1002/art.24699